Given that FOXM1 was found to “brainwash” normal cells by reprograming the methylome and changing its landscape toward those found in cancer cells (Teh et al., 2012), the global epigenomic perturbations orchestrated by FOXM1 during pre-cancer initiation may therefore contain clinically exploitable predictive cancer biomarkers. Here, FOXM1 is linked to cancer.